REGAL-BELOIT CORPORATION
$150,000,000 Floating Rate Series 2007A Senior Notes, Tranche
A,
due August 23, 2014
$100,000,000 Floating Rate Series 2007A Senior Notes, Tranche
B,
due August 23, 2017
_________________
NOTE PURCHASE AGREEMENT
_________________
DATED AS OF AUGUST 23, 2007
TABLE OF CONTENTS
| SECTION |
HEADING |
PAGE |
SECTION 1. |
AUTHORIZATION OF NOTES |
1 |
|
|
|
Section 1.1. |
Description
of Notes |
1 |
| Section 1.2. |
Interest
Rate |
2 |
|
|
|
SECTION 2. |
SALE AND
PURCHASE OF NOTES |
3 |
|
|
|
Section 2.1. |
Series 2007A
Notes |
3 |
| Section 2.2. |
Additional
Series of Notes |
3 |
| Section 2.3. |
Subsidiary
Guaranty |
5 |
|
|
|
SECTION 3. |
CLOSING |
5 |
|
|
|
|
|
|
SECTION 4. |
CONDITIONS
TO CLOSING |
6 |
|
|
|
Section 4.1. |
Representations and Warranties |
6 |
| Section 4.2. |
Performance;
No Default |
6 |
| Section 4.3. |
Compliance
Certificates |
6 |
| Section 4.4. |
Opinions of
Counsel |
7 |
| Section 4.5. |
Purchase
Permitted By Applicable Law, Etc. |
7 |
| Section 4.6. |
Sale of
Other Notes |
7 |
| Section 4.7. |
Payment of
Special Counsel Fees |
7 |
| Section 4.8. |
Private
Placement Number |
7 |
| Section 4.9. |
Changes in
Corporate Structure |
7 |
| Section 4.10. |
Subsidiary
Guaranty |
8 |
| Section 4.11. |
Funding
Instructions |
8 |
| Section 4.12. |
Proceedings
and Documents |
8 |
| Section 4.13. |
Notice of
Floating Interest Rate |
8 |
| Section 4.14. |
Intercreditor Agreement |
8 |
|
|
|
SECTION 5. |
REPRESENTATIONS AND WARRANTIES OF THE COMPANY |
8 |
|
|
|
Section 5.1. |
Organization; Power and Authority |
8 |
| Section 5.2. |
Authorization, Etc. |
8 |
| Section 5.3. |
Disclosure |
9 |
| Section 5.4. |
Organization
and Ownership of Shares of Subsidiaries; Affiliates |
9 |
| Section 5.5. |
Financial
Statements; Material Liabilities |
10 |
| Section 5.6. |
Compliance
with Laws, Other Instruments, Etc. |
10 |
| Section 5.7. |
Governmental
Authorizations, Etc. |
10 |
| Section 5.8. |
Litigation;
Observance of Agreements, Statutes and Orders |
11 |
| Section 5.9. |
Taxes |
11 |
| Section 5.10. |
Title to
Property; Leases |
11 |
| Section 5.11. |
Licenses,
Permits, Etc. |
11 |
-i-
|
|
|
| Section 5.12. |
Compliance
with ERISA |
12 |
| Section 5.13. |
Private
Offering by the Company |
13 |
| Section 5.14. |
Use of
Proceeds; Margin Regulations |
13 |
| Section 5.15. |
Existing
Debt; Future Liens |
13 |
| Section 5.16. |
Foreign
Assets Control Regulations, Etc. |
14 |
| Section 5.17. |
Status under
Certain Statutes |
14 |
| Section 5.18. |
Environmental Matters |
14 |
| Section 5.19. |
Notes Rank
Pari Passu |
15 |
SECTION 6. |
REPRESENTATIONS OF THE PURCHASER |
15 |
Section 6.1. |
Purchase for
Investment |
15 |
| Section 6.2. |
Accredited
Investor |
15 |
| Section 6.3. |
Source of
Funds |
16 |
SECTION 7. |
INFORMATION
AS TO COMPANY |
17 |
Section 7.1. |
Financial
and Business Information |
17 |
| Section 7.2. |
Officer's
Certificate |
20 |
| Section 7.3. |
Visitation |
20 |
SECTION 8. |
PAYMENT OF
THE NOTES |
21 |
Section 8.1. |
Required
Prepayments |
21 |
| Section 8.2. |
Optional
Prepayments with Prepayment Premium |
21 |
| Section 8.3. |
Allocation
of Partial Prepayments |
22 |
| Section 8.4. |
Maturity;
Surrender, Etc. |
22 |
| Section 8.5. |
Purchase of
Notes |
22 |
| Section 8.6. |
Change in
Control |
23 |
SECTION 9. |
AFFIRMATIVE
COVENANTS |
25 |
Section 9.1. |
Compliance
with Law |
25 |
| Section 9.2. |
Insurance |
25 |
| Section 9.3. |
Maintenance
of Properties |
25 |
| Section 9.4. |
Payment of
Taxes |
26 |
| Section 9.5. |
Corporate
Existence, Etc. |
26 |
| Section 9.6. |
Notes to
Rank Pari Passu |
26 |
| Section 9.7. |
Subsidiary
Guarantors |
26 |
| Section 9.8. |
Books and
Records |
27 |
| Section 9.9. |
Intercreditor Agreement |
27 |
SECTION 10. |
NEGATIVE
COVENANTS |
27 |
Section 10.1. |
Consolidated
Debt to Consolidated EBITDA |
27 |
| Section 10.2. |
Interest
Coverage Ratio |
27 |
| Section 10.3. |
Subsidiary
Debt |
28 |
| Section 10.4. |
Securitization Obligations |
28 |
| Section 10.5. |
Limitation
on Liens |
29 |
-ii-
|
|
|
| Section 10.6. |
Sale of
Assets |
31 |
| Section 10.7. |
Merger and
Consolidation |
32 |
| Section 10.8. |
Transactions
with Affiliates |
33 |
| Section 10.9. |
Terrorism
Sanctions Regulations |
34 |
| Section 10.10. |
Non-Guarantor Domestic Subsidiaries |
34 |
| Section 10.11. |
Most Favored
Lender's Covenant |
34 |
SECTION 11. |
EVENTS OF
DEFAULT |
35 |
SECTION 12. |
REMEDIES ON
DEFAULT, ETC. |
37 |
Section 12.1. |
Acceleration |
37 |
| Section 12.2. |
Other
Remedies |
38 |
| Section 12.3. |
Rescission |
38 |
| Section 12.4. |
No Waivers
or Election of Remedies, Expenses, Etc. |
38 |
SECTION 13. |
REGISTRATION; EXCHANGE; SUBSTITUTION OF NOTES |
39 |
Section 13.1. |
Registration
of Notes |
39 |
| Section 13.2. |
Transfer and
Exchange of Notes |
39 |
| Section 13.3. |
Replacement
of Notes |
39 |
SECTION 14. |
PAYMENTS ON
NOTES |
40 |
Section 14.1. |
Place of
Payment |
40 |
| Section 14.2. |
Home Office
Payment |
40 |
SECTION 15. |
EXPENSES,
ETC. |
41 |
Section 15.1. |
Transaction
Expenses |
41 |
| Section 15.2. |
Survival |
41 |
SECTION 16. |
SURVIVAL OF
REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT |
41 |
SECTION 17. |
AMENDMENT
AND WAIVER |
42 |
Section 17.1. |
Requirements |
42 |
| Section 17.2. |
Solicitation
of Holders of Notes |
43 |
| Section 17.3. |
Binding
Effect, Etc. |
43 |
| Section 17.4. |
Notes Held
by Company, Etc. |
43 |
SECTION 18. |
NOTICES |
44 |
SECTION 19. |
REPRODUCTION
OF DOCUMENTS |
44 |
SECTION 20. |
CONFIDENTIAL
INFORMATION |
45 |
-iii-
|
|
|
| SECTION
21. |
SUBSTITUTION
OF PURCHASER |
46 |
SECTION 22. |
MISCELLANEOUS |
46 |
Section 22.1. |
Successors
and Assigns |
46 |
| Section 22.2. |
Payments Due
on Non-Business Days |
46 |
| Section 22.3. |
Accounting
Terms |
47 |
| Section 22.4. |
Severability |
47 |
| Section 22.5. |
Construction |
47 |
| Section 22.6. |
Counterparts |
47 |
| Section 22.7. |
Governing
Law |
47 |
| Section 22.8. |
Jurisdiction
and Process; Waiver of Jury Trial |
47 |
| Section 22.9. |
Subordination of Indenture |
48 |
-iv-
|
|
|
| SCHEDULE A |
-- |
INFORMATION RELATING TO PURCHASERS |
SCHEDULE B |
-- |
DEFINED
TERMS |
SCHEDULE 4.9 |
-- |
Changes in
Corporate Structure |
SCHEDULE 5.4 |
-- |
Subsidiaries
of the Company, Ownership of Subsidiary Stock,
Affiliates |
SCHEDULE 5.5 |
-- |
Financial
Statements |
SCHEDULE 5.8(a) |
-- |
Litigation |
SCHEDULE 5.11 |
-- |
Licenses,
Permits, Etc. |
SCHEDULE 5.15 |
-- |
Existing
Debt |
SCHEDULE 10.3 |
-- |
Subsidiary
Debt |
SCHEDULE 10.5 |
-- |
Existing
Liens |
EXHIBIT 1(a) |
-- |
Form of
Floating Rate Series 2007A Senior Notes, Tranche A, due August 23,
2014 |
EXHIBIT 1(b) |
-- |
Form of
Floating Rate Series 2007A Senior Notes, Tranche B, due August 23,
2017 |
EXHIBIT 2.3 |
-- |
Form of
Subsidiary Guaranty |
EXHIBIT 3 |
-- |
Form of
Intercreditor Agreement |
EXHIBIT 4.4(a) |
-- |
Form of
Opinion of General Counsel to the Company |
EXHIBIT 4.4(b) |
-- |
Form of
Opinion of Special Counsel to the Company |
EXHIBIT 4.4(c) |
-- |
Form of
Opinion of Special Counsel to the Purchasers |
EXHIBIT S |
-- |
Form of
Supplement to Note Purchase Agreement |
-v-
REGAL-BELOIT CORPORATION
200 State Street
Beloit, WI 53511
$150,000,000 Floating Rate Series 2007A Senior Notes, Tranche
A,
due August 23, 2014
$100,000,000 Floating Rate Series 2007A Senior Notes, Tranche
B,
due August 23, 2017
Dated as of
August 23, 2007
TO THE
PURCHASERS LISTED IN
THE
ATTACHED SCHEDULE A:
Ladies and Gentlemen:
REGAL-BELOIT
CORPORATION, a Wisconsin corporation (the
“Company” ), agrees with the Purchasers listed
in the attached Schedule A (the
“Purchasers” ) to this Note Purchase Agreement
(this “Agreement” ) as follows:
SECTION
1. AUTHORIZATION OF NOTES.
Section 1.1.
Description of
Notes . The Company will authorize the issue and sale of the
following Senior Notes:
| ISSUE |
SERIES
AND/OR
TRANCHE |
AGGREGATE
PRINCIPAL
AMOUNT |
INTEREST
RATE |
MATURITY
DATE |
|
|
|
|
|
| Senior Notes |
Series 2007A,
Tranche A |
$150,000,000 |
Floating Rate |
August 23, 2014 |
|
|
|
|
|
| Senior
Notes |
Series
2007A,
Tranche B |
$100,000,000 |
Floating
Rate |
August 23,
2017 |
The Senior
Notes described above are individually referred to respectively as
the “Tranche A Notes” and the “Tranche
B Notes”, and are collectively referred to as the
“Series 2007A Notes” . The Series 2007A Notes
described above together with each Series of Additional Notes which
may from time to time be issued pursuant to the provisions of
Section 2.2 are collectively referred to as the
“Notes” (such term shall also include any such
notes issued in substitution therefor pursuant to Section 13
of this Agreement). The Tranche A Notes and the Tranche B Notes
shall be substantially in the form set out in Exhibit 1(a) and
Exhibit 1(b), respectively, with such changes therefrom, if
any, as may be approved by the Purchasers and the Company. Certain
capitalized terms used in this Agreement are defined in
Schedule B; references to a “Schedule” or an
“Exhibit” are, unless otherwise specified, to a
Schedule or an Exhibit attached to this Agreement.
Section 1.2.
Interest Rate.
(a)(i) The Series 2007A Notes shall bear interest
(computed on the basis of a 360-day year and actual days elapsed)
on the unpaid principal thereof from the date of issuance at a
floating rate equal to the Adjusted LIBOR Rate from time to time,
payable quarterly on the 23rd day of February, May, August and
November in each year and at maturity, commencing on
November 23rd, 2007, until such principal sum shall have
become due and payable (whether at maturity, upon notice of
prepayment or otherwise) (each such date being referred to herein
as an “Interest Payment Date” ) and interest (so
computed) on any overdue principal or interest or Prepayment
Premium or LIBOR Breakage Amount from the due date thereof (whether
by acceleration or otherwise) and, during the continuance of an
Event of Default, on the unpaid balance hereof, at the applicable
Default Rate until paid.
(ii)
The Adjusted LIBOR Rate for the respective tranche of
Series 2007A Notes shall be determined by the Company, and
notice thereof shall be given to the holders of the
Series 2007A Notes, within three Business Days after the
beginning of each Interest Period, together with a copy of the
relevant screen used for the determination of LIBOR, a calculation
of Adjusted LIBOR Rate for such Interest Period, the number of days
in such Interest Period, the date on which interest for such
Interest Period will be paid and the amount of interest to be paid
to each holder of Series 2007A Notes on such date. In the
event that the holders of more than 50% in aggregate outstanding
principal amount of any of the Tranche A Notes or Tranche B Notes
do not concur with such determination by the Company, within ten
Business Days after receipt by such holders of the notice delivered
by the Company pursuant to the immediately preceding sentence, such
holders of the Tranche A Notes or Tranche B Notes, as the case may
be, shall provide notice to the Company, together with a copy of
the relevant screen used for the determination of LIBOR, a
calculation of Adjusted LIBOR Rate for such Interest Period, the
number of days in such Interest Period, the date on which interest
for such Interest Period will be paid and the amount of interest to
be paid to each holder of Tranche A Notes or Tranche B Notes
on such date, as the case may be, and any such determination made
in accordance with the provisions of this Agreement, shall be
presumptively correct absent manifest error.
(b)
If, during a Transition Period, the Consolidated Debt to
Consolidated EBITDA ratio exceeds 3.75 to 1.00, as evidenced by an
Officer’s Certificate delivered pursuant to
Section 7.2(a), the applicable per annum interest rate payable
on the Notes shall be increased by 0.25%, commencing on the first
day of the first fiscal quarter following the fiscal quarter in
respect of which such Certificate was delivered and continuing
until the Company has provided an Officer’s Certificate
pursuant to Section 7.2(a) demonstrating that, as of the end of the
fiscal quarter in respect of which such Certificate is delivered,
the Consolidated Debt to Consolidated EBITDA ratio is not more than
3.75 to 1.0. Following delivery of an Officer’s
Certificate demonstrating that the Consolidated Debt to
Consolidated EBITDA ratio did not exceed 3.75 to 1.0, the
additional 0.25% interest shall cease to accrue or be payable for
any fiscal quarter subsequent to the fiscal quarter in respect of
which such Certificate is delivered.
-2-
SECTION
2. SALE AND PURCHASE OF NOTES.
Section 2.1.
Series 2007A
Notes. Subject to the terms and conditions of this Agreement,
the Company will issue and sell to each Purchaser and each
Purchaser will purchase from the Company, at the Closing provided
for in Section 3, the Series 2007A Notes in the principal
amount specified opposite such Purchaser’s name in
Schedule A at the purchase price of 100% of the principal
amount thereof. The obligations of each Purchaser hereunder are
several and not joint obligations and no Purchaser shall have any
obligation or any liability to any Person for the performance or
nonperformance by any other Purchaser hereunder.
Section 2.2.
Additional
Series of Notes . The Company may, from time to time, in
its sole discretion but subject to the terms hereof, issue and sell
one or more additional Series of its unsecured promissory notes
under the provisions of this Agreement pursuant to a supplement (a
“Supplement” ) substantially in the form of
Exhibit S, provided that the aggregate principal amount
of all Additional Notes (as defined below) issued pursuant to all
Supplements in accordance with the terms of this Section 2.2,
when added together with the original aggregate principal amount of
the Series 2007A Notes, shall not exceed $600,000,000. Each
additional Series of Notes (the “Additional
Notes” ) issued pursuant to a Supplement shall be subject
to the following terms and conditions:
|
(i)
each Series of Additional Notes, when so issued, shall be
differentiated from all previous Series by sequential alphabetical
designation inscribed thereon;
|
|
(ii)
Additional Notes of the same Series may consist of more than one
different and separate tranches and may differ with respect to
outstanding principal amounts, maturity dates, interest rates and
premiums, if any, and price and terms of redemption or payment
prior to maturity, but subject to Section 17.1(c) all such
different and separate tranches of the same Series shall vote as a
single class and constitute one Series;
|
|
(iii)
each Series of Additional Notes shall be dated the date of issue,
bear interest at such rate or rates, mature on such date or dates,
be subject to such mandatory and optional prepayment on the dates
and at the premiums, if any, have such additional or different
conditions precedent to closing, such representations and
warranties and such covenants as shall be specified in the
Supplement under which such Additional Notes are issued and upon
execution of any such Supplement, this Agreement shall be amended
(a) to reflect any additional covenants without further action on
the part of the holders of the Notes outstanding under this
Agreement, provided , that any such additional covenant
shall not impair, diminish or otherwise adversely modify any
existing covenants contained herein, provided further , that
any such additional covenants shall inure to the benefit of all
holders of Notes so long as any Additional Notes issued pursuant to
such Supplement remain outstanding, and (b) to reflect such
representations and warranties as are contained in such Supplement
for the benefit of the holders of such Additional Notes in
accordance with the provisions of Section 16;
|
-3-
|
(iv)
each Series of Additional Notes issued under this Agreement shall
be in substantially the form of Exhibit 1 to Exhibit S
hereto with such variations, omissions and insertions as are
necessary or permitted hereunder;
|
|
(v)
the minimum principal amount of any Note issued under a Supplement
shall be $100,000, except as may be necessary to evidence the
outstanding amount of any Note originally issued in a denomination
of $100,000 or more;
|
|
(vi)
all Additional Notes shall constitute Senior Debt of the Company
and shall rank pari passu with all other outstanding Notes;
and
|
|
(vii)
no Additional Notes shall be issued hereunder if at the time of
issuance thereof and after giving effect to the application of the
proceeds thereof, any Default or Event of Default shall have
occurred and be continuing.
|
The obligations
of the Additional Purchasers to purchase any Additional Notes shall
be subject to the following conditions precedent, in addition to
the conditions specified in the Supplement pursuant to which such
Additional Notes may be issued:
|
(a)
Compliance Certificate . A duly authorized Senior Financial
Officer shall execute and deliver to each Additional Purchaser an
Officer’s Certificate dated the date of issue of such Series
of Additional Notes stating that such officer has reviewed the
provisions of this Agreement (including any Supplements hereto) and
setting forth the information and computations (in sufficient
detail) required in order to establish whether after giving effect
to the issuance of the Additional Notes and after giving effect to
the application of the proceeds thereof, the Company is in
compliance with the requirements of Section 10.1 on such date
(based upon the financial statements for the most recent fiscal
quarter ended prior to the date of such certificate).
|
|
(b)
Execution and Delivery of Supplement. The Company and each
such Additional Purchaser shall execute and deliver a Supplement
substantially in the form of Exhibit S hereto.
|
|
(c)
Representations of Additional Purchasers . Each Additional
Purchaser shall have confirmed in the Supplement that the
representations set forth in Section 6 are true with respect
to such Additional Purchaser on and as of the date of issue of the
Additional Notes.
|
|
(d)
Execution and Delivery of Guaranty Ratification. Provided
that a Collateral Release shall not have occurred, each Subsidiary
Guarantor shall execute and deliver a Guaranty Ratification in the
form attached to the Subsidiary Guaranty.
|
-4-
Section
2.3. Subsidiary Guaranty. (a) The payment by the
Company of all amounts due with respect to the Notes and the
performance by the Company of its obligations under this Agreement
will be absolutely and unconditionally guaranteed by the Subsidiary
Guarantors pursuant to the Subsidiary Guaranty Agreement, dated as
of even date herewith, which shall be substantially in the form of
Exhibit 2.3 attached hereto, and otherwise in accordance with
the provisions of Section 9.7 hereof (the “Subsidiary
Guaranty” ).
(b)
Any Subsidiary Guarantor shall be released from its obligation
under a Subsidiary Guaranty (i) if such Subsidiary Guarantor
has been released and discharged (or will be released and
discharged concurrently with the release of such Subsidiary
Guarantor under the Subsidiary Guaranty) as an obligor and
guarantor under and in respect of the Bank Credit Agreement and the
Company so certifies to the holders of the Notes in a certificate
of a Responsible Officer, (ii) at the time of such release and
discharge, the Company shall deliver a certificate of a Responsible
Officer to the holders of the Notes stating that no Default or
Event of Default exists (including, without limitation, under
Section 10.10 hereof), and (iii) if any fee or other form
of consideration is given to any holder of Debt of the Company
expressly for the purpose of such release, holders of the Notes
shall receive equivalent consideration (a “Collateral
Release” ).
(c)
A Subsidiary Guarantor shall be automatically released from the
Subsidiary Guaranty in accordance with the terms of Section 25 of
the Subsidiary Guaranty.
SECTION
3. CLOSING.
The sale and
purchase of the Series 2007A Notes to be purchased by each
Purchaser shall occur at the offices of Chapman and Cutler LLP,
111 West Monroe St., Chicago, Illinois 60603, at
10:00 a.m. Central time, at a closing (the
“Closing” ) on August 23, 2007 or on such other
Business Day thereafter on or prior to August 31, 2007 as may be
agreed upon by the Company and the Purchasers (the
“Closing Date” ). On the Closing Date, the
Company will deliver to each Purchaser the Series 2007A Notes
to be purchased by such Purchaser in the form of a single
Series A Note (or such greater number of Series 2007A
Notes in denominations of at least $100,000 as such Purchaser may
request) dated the date of the Closing Date and registered in such
Purchaser’s name (or in the name of such Purchaser’s
nominee), against delivery by such Purchaser to the Company or its
order of immediately available funds in the amount of the purchase
price therefor by wire transfer of immediately available funds for
the account of the Company to Account Number 1216201, at M&I
Marshall & Ilsley Bank, Milwaukee, WI, ABA Number 075000051, in
the Account Name of “Regal-Beloit Corporation” If, on
the Closing Date, the Company shall fail to tender such
Series 2007A Notes to any Purchaser as provided above in this
Section 3, or any of the conditions specified in
Section 4 shall not have been fulfilled to any
Purchaser’s satisfaction, such Purchaser shall, at such
Purchaser’s election, be relieved of all further obligations
under this Agreement, without thereby waiving any rights such
Purchaser may have by reason of such failure or such
nonfulfillment.
-5-
SECTION
4. CONDITIONS TO CLOSING.
Each
Purchaser’s obligation to purchase and pay for the
Series 2007A Notes to be sold to such Purchaser at the Closing
is subject to the fulfillment to such Purchaser’s
satisfaction, prior to or at the Closing, of the following
conditions applicable to the Closing Date:
Section
4.1. Representations and Warranties.
(a)
Representations and Warranties of the Company. The
representations and warranties of the Company in this Agreement
shall be correct when made and at the time of the
Closing.
(b)
Representations and Warranties of the Subsidiary Guarantors.
The representations and warranties of the Subsidiary Guarantors in
the Subsidiary Guaranty shall be correct when made and at the time
of the Closing.
Section 4.2.
Performance; No
Default . The Company and each Subsidiary Guarantor shall have
performed and complied in all material respects with all agreements
and conditions contained in this Agreement and the Subsidiary
Guaranty required to be performed or complied with by the Company
and each such Subsidiary Guarantor prior to or at the Closing, and
after giving effect to the issue and sale of the Series 2007A
Notes (and the application of the proceeds thereof as contemplated
by Section 5.14), no Default or Event of Default shall have
occurred and be continuing. Neither the Company nor any Subsidiary
shall have entered into any transaction since the date of the
Memorandum that would have been prohibited by Section 10
hereof had such Sections applied since such date.
Section 4.3.
Compliance
Certificates .
(a)
Officer’s Certificate of the Company. The Company
shall have delivered to such Purchaser an Officer’s
Certificate, dated the Closing Date, certifying that the conditions
specified in Sections 4.1, 4.2 and 4.9 have been
fulfilled.
(b)
Secretary’s Certificate of the Company. The Company
shall have delivered to such Purchaser a certificate, dated the
Closing Date, certifying as to the resolutions attached thereto and
other corporate proceedings relating to the authorization,
execution and delivery of the Series 2007A Notes and this
Agreement.
(c)
Officer’s Certificate of the Subsidiary Guarantors.
Each Subsidiary Guarantor shall have delivered to such Purchaser an
Officer’s Certificate, dated the Closing Date, certifying
that the conditions specified in Sections 4.1(b), 4.2 and 4.9 have
been fulfilled.
(d)
Secretary’s Certificate of the Subsidiary Guarantors.
Each Subsidiary Guarantor shall have delivered to such Purchaser a
certificate, dated the Closing Date, certifying as to the
resolutions attached thereto and other corporate proceedings
relating to the authorization, execution and delivery of the
Subsidiary Guaranty.
-6-
Section 4.4.
Opinions of
Counsel . Such Purchaser shall have received opinions in form
and substance satisfactory to such Purchaser, dated the Closing
Date (a) from Paul J. Jones, Vice President,
Secretary and General Counsel of the Company, covering the matters
set forth in Exhibit 4.4(a) and covering such other matters
incident to the transactions contemplated hereby as such Purchaser
or its counsel may reasonably request (and the Company hereby
instructs its counsel to deliver such opinion to the Purchasers),
(b) from Foley & Lardner LLP, special counsel for the
Company, covering the matters set forth in Exhibit 4.4(b) and
covering such other matters incident to the transactions
contemplated hereby as such Purchaser or its counsel may reasonably
request (and the Company hereby instructs its counsel to deliver
such opinion to the Purchasers), and (c) from Chapman and
Cutler LLP, the Purchasers’ special counsel in connection
with such transactions, substantially in the form set forth in
Exhibit 4.4(c) and covering such other matters incident to
such transactions as such Purchaser may reasonably
request.
Section 4.5.
Purchase Permitted By
Applicable Law, Etc . On the date of the Closing such
Purchaser’s purchase of Series 2007A Notes shall
(a) be permitted by the laws and regulations of each
jurisdiction to which such Purchaser is subject, without recourse
to provisions (such as section 1405(a)(8) of the New York
Insurance Law) permitting limited investments by insurance
companies without restriction as to the character of the particular
investment, (b) not violate any applicable law or regulation
(including, without limitation, Regulation T, U or X of the
Board of Governors of the Federal Reserve System) and (c) not
subject such Purchaser to any tax, penalty or liability under or
pursuant to any applicable law or regulation, which law or
regulation was not in effect on the date hereof. If requested by
such Purchaser, such Purchaser shall have received an
Officer’s Certificate certifying as to such matters of fact
as such Purchaser may reasonably specify to enable such Purchaser
to determine whether such purchase is so permitted.
Section 4.6.
Sale of Other
Notes . Contemporaneously with the Closing the Company shall
sell to each other Purchaser and each other Purchaser shall
purchase the Series 2007A Notes to be purchased by it at the
Closing as specified in Schedule A.
Section 4.7.
Payment of Special
Counsel Fees . Without limiting the provisions of
Section 15.1, the Company shall have paid on or before the
Closing Date, the reasonable fees, reasonable charges and
reasonable disbursements of the Purchasers’ special counsel
referred to in Section 4.4 to the extent reflected in a
statement of such counsel rendered to the Company at least one
Business Day prior to the Closing Date.
Section 4.8.
Private Placement
Number . A Private Placement Number issued by Standard &
Poor’s CUSIP Service Bureau (in cooperation with the
Securities Valuation Office of the National Association of
Insurance Commissioners) shall have been obtained for each tranche
of the Series 2007A Notes.
Section 4.9.
Changes in Corporate
Structure . Neither the Company nor any Subsidiary Guarantor
shall have changed its jurisdiction of organization or, except as
reflected in Schedule 4.9, been a party to any merger or
consolidation, or shall have succeeded to all or any substantial
part of the liabilities of any other entity, at any time following
the date of the most recent financial statements referred to in
Schedule 5.5.
-7-
Section
4.10. Subsidiary Guaranty. The Subsidiary Guaranty shall
have been duly authorized, executed and delivered by each
Subsidiary Guarantor, shall constitute the legal, valid and binding
contract and agreement of each Subsidiary Guarantor and such
Purchaser shall have received a true, correct and complete copy
thereof.
Section 4.11.
Funding
Instructions . At least three Business Days prior to the date
of the Closing, each Purchaser shall have received written
instructions signed by a Responsible Officer on letterhead of the
Company confirming the information specified in Section 3
including (i) the name and address of the transferee bank,
(ii) such transferee bank’s ABA number and
(iii) the account name and number into which the purchase
price for the Series 2007A Notes is to be
deposited.
Section 4.12.
Proceedings and
Documents . All corporate and other organizational proceedings
in connection with the transactions contemplated by this Agreement
and all documents and instruments incident to such transactions
shall be satisfactory to such Purchaser and its special counsel,
and such Purchaser and its special counsel shall have received all
such counterpart originals or certified or other copies of such
documents as such Purchaser or such special counsel may reasonably
request.
Section 4.13.
Notice of Floating
Interest Rate . At least one Business Day prior to the Closing
Date, each Purchaser of the Series 2007A Notes shall have
received written notice from the Company of LIBOR and the Adjusted
LIBOR Rate for the initial Interest Period, all as set forth in
Section 1.2(a)(ii).
Section 4.14.
Intercreditor
Agreement. The Intercreditor Agreement shall be reasonably
satisfactory in scope, form and substance to such Purchaser, shall
have been duly executed and delivered by the parties thereto, shall
constitute the legal, valid and binding contract and agreement of
each of the parties thereto, and such Purchaser shall have received
a true, complete, executed copy thereof.
SECTION
5. REPRESENTATIONS AND WARRANTIES OF THE
COMPANY.
The Company
represents and warrants to each Purchaser that:
Section 5.1.
Organization; Power
and Authority . The Company is a corporation duly organized,
validly existing and in good standing (or equivalent) under the
laws of its jurisdiction of incorporation, and is duly qualified as
a foreign corporation and is in good standing (or equivalent) in
each jurisdiction in which such qualification is required by law,
other than those jurisdictions as to which the failure to be so
qualified or in good standing would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse
Effect. The Company has the corporate power and authority to own or
hold under lease the properties it purports to own or hold under
lease, to transact the business it transacts and proposes to
transact, to execute and deliver this Agreement and the
Series 2007A Notes and to perform the provisions hereof and
thereof.
-8-
Section 5.2.
Authorization,
Etc . This Agreement and the Notes to be issued on the Closing
Date have been duly authorized by all necessary corporate action on
the part of the Company, and this Agreement constitutes, and upon
execution and delivery thereof each such Note will constitute, a
legal, valid and binding obligation of the Company enforceable
against the Company in accordance with its terms, except as such
enforceability may be limited by (i) applicable bankruptcy,
insolvency, reorganization, moratorium or other similar laws
affecting the enforcement of creditors’ rights generally and
(ii) general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or at
law).
Section 5.3.
Disclosure . The
Company, through its agent, Banc of America Securities LLC, has
delivered to you and each Other Purchaser a copy of a Private
Placement Memorandum, dated July, 2007 (the
“Memorandum” ), relating to the transactions
contemplated hereby. The Memorandum fairly describes, in all
material respects, the general nature of the business and principal
properties of the Company and its Subsidiaries. This Agreement, the
Memorandum, the documents, certificates or other writings delivered
to the Purchasers by or on behalf of the Company in connection with
the transactions contemplated hereby and the financial statements
listed in Schedule 5.5, in each case, delivered to the
Purchasers prior to July 25, 2007 (this Agreement, the Memorandum
and such documents, certificates or other writings and such
financial statements being referred to, collectively, as the
“Disclosure Documents” ), taken as a whole, do
not contain any untrue statement of a material fact or omit to
state any material fact necessary to make the statements therein
not misleading in light of the circumstances under which they were
made and on the date when made and as of the Closing Date. Except
as disclosed in the Disclosure Documents, since December 31,
2006, there has been no change in the financial condition,
operations, business or properties of the Company or any of its
Subsidiaries except changes that individually or in the aggregate
would not reasonably be expected to have a Material Adverse Effect.
There is no liability known to the Company that would reasonably be
expected to have a Material Adverse Effect that has not been set
forth herein or in the Disclosure Documents. For purposes of this
Section 5.3, posting of the Memorandum on Intralinks shall
constitute delivery of the Memorandum to the Purchasers.
Section 5.4.
Organization and
Ownership of Shares of Subsidiaries; Affiliates .
(a) Schedule 5.4 contains (except as noted therein)
complete and correct lists (i) of the Company’s
Subsidiaries, showing, as to each Subsidiary, the correct name
thereof, the jurisdiction of its organization, and the percentage
of shares of each class of its capital stock or similar equity
interests outstanding owned by the Company and each other
Subsidiary, (ii) of the Company’s Affiliates, other than
Subsidiaries, and (iii) of the Company’s directors and
senior officers.
(b)
All of the outstanding shares of capital stock or similar equity
interests of each Subsidiary shown in Schedule 5.4 as being
owned by the Company and its Subsidiaries have been validly issued,
are fully paid and nonassessable and are owned by the Company or
another Subsidiary free and clear of any Lien (except as otherwise
disclosed in Schedule 5.4).
-9-
(c)
Each Subsidiary identified in Schedule 5.4 is a corporation or
other legal entity duly organized, validly existing and in good
standing (or equivalent) under the laws of its jurisdiction of
organization, and is duly qualified as a foreign corporation or
other legal entity and is in good standing in each jurisdiction in
which such qualification is required by law, other than those
jurisdictions as to which the failure to be so qualified or in good
standing would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. Each such Subsidiary
has the corporate or other power and authority to own or hold under
lease the properties it purports to own or hold under lease and to
transact the business it transacts and proposes to transact except
where the failure to have same would not have a Material Adverse
Effect.
(d)
No Subsidiary is a party to, or otherwise subject to, any legal
restriction or any agreement (other than this Agreement, the
agreements listed on Schedule 5.4 and customary limitations
imposed by corporate law statutes) restricting the ability of such
Subsidiary to pay dividends out of profits or make any other
similar distributions of profits to the Company or any of its
Subsidiaries that owns outstanding shares of capital stock or
similar equity interests of such Subsidiary except for any such
restrictions that could not reasonably be expected to have a
Material Adverse Effect.
Section 5.5.
Financial Statements;
Material Liabilities . The Company has delivered to each
Purchaser copies of the financial statements of the Company and its
Subsidiaries listed on Schedule 5.5. All of said financial
statements (including in each case the related schedules and notes)
fairly present in all material respects the consolidated financial
position of the Company and its Subsidiaries as of the respective
dates specified in such Schedule and the consolidated results of
their operations and cash flows for the respective periods so
specified and have been prepared in accordance with GAAP
consistently applied throughout the periods involved except as set
forth in the notes thereto (subject, in the case of any interim
financial statements, to normal year-end adjustments). The Company
and its Subsidiaries do not have any Material liabilities that are
not disclosed on such financial statements or otherwise disclosed
in the Disclosure Documents.
Section 5.6.
Compliance with Laws,
Other Instruments, Etc . The execution, delivery and
performance by the Company of this Agreement and the
Series 2007A Notes will not (a) contravene, result in any
breach of, or constitute a default under, or result in the creation
of any Lien in respect of any property of the Company or any
Subsidiary under, any indenture, mortgage, deed of trust, loan,
purchase or credit agreement, lease, corporate charter or by-laws,
or any other agreement or instrument to which the Company or any
Subsidiary is bound or by which the Company or any Subsidiary or
any of their respective properties may be bound or affected,
(b) conflict with or result in a breach of any of the terms,
conditions or provisions of any order, judgment, decree, or ruling
of any court, arbitrator or Governmental Authority applicable to
the Company or any Subsidiary, or (c) violate any provision of
any statute or other rule or regulation of any Governmental
Authority applicable to the Company or any Subsidiary.
Section 5.7.
Governmental
Authorizations, Etc . No consent, approval or authorization of,
or registration, filing or declaration with, any Governmental
Authority is required in connection with the execution, delivery or
performance by the Company of this Agreement or the
Series 2007A Notes except for certain filings on form 8-K
as may be required by Rule 13a-11 of the Securities Exchange
Act of 1934, as amended.
-10-
Section 5.8.
Litigation;
Observance of Agreements, Statutes and Orders . (a) Except
as disclosed on Schedule 5.8, there are no actions, suits,
investigations or proceedings pending or, to the knowledge of the
Company, threatened against or affecting the Company or any
Subsidiary or any property of the Company or any Subsidiary in any
court or before any arbitrator of any kind or before or by any
Governmental Authority that, individually or in the aggregate,
would reasonably be expected to have a Material Adverse
Effect.
(b)
Neither the Company nor any Subsidiary is in default under any term
of any agreement or instrument to which it is a party or by which
it is bound, or any order, judgment, decree or ruling of any court,
arbitrator or Governmental Authority or is in violation of any
applicable law, ordinance, rule or regulation (including without
limitation Environmental Laws or the USA Patriot Act) of any
Governmental Authority, which default or violation, individually or
in the aggregate, would reasonably be expected to have a Material
Adverse Effect.
Section 5.9.
Taxes . The
Company and its Subsidiaries have filed all tax returns that are
required to have been filed in any jurisdiction, and have paid all
taxes shown to be due and payable on such returns and all other
taxes and assessments levied upon them or their properties, assets,
income or franchises, to the extent such taxes and assessments have
become due and payable and before they have become delinquent,
except for any taxes and assessments (a) the amount of which
is not individually or in the aggregate Material or (b) the
amount, applicability or validity of which is currently being
contested in good faith by appropriate proceedings and with respect
to which the Company or a Subsidiary, as the case may be, has
established adequate reserves in accordance with GAAP. The Company
knows of no basis for any other tax or assessment that would
reasonably be expected to have a Material Adverse Effect. The
charges, accruals and reserves on the books of the Company and its
Subsidiaries in respect of federal, state or other taxes for all
fiscal periods are adequate in all Material respects. The federal
income tax liabilities of the Company and its Subsidiaries have
been finally determined (whether by reason of completed audits or
the statute of limitations having run) for all fiscal years up to
and including the fiscal year ended December 31, 2002.
Section 5.10.
Title to Property;
Leases . The Company and its Subsidiaries have good and
sufficient title to their respective properties which the Company
and its Subsidiaries own or purport to own that individually or in
the aggregate are Material, including, if material under GAAP, all
such properties reflected in the most recent audited balance sheet
referred to in Section 5.5 or purported to have been acquired
by the Company or any Subsidiary after said date (except as sold or
otherwise disposed of in the ordinary course of business), in each
case free and clear of Liens prohibited by this Agreement. All
leases that individually or in the aggregate are Material are valid
and subsisting and are in full force and effect in all material
respects.
Section 5.11.
Licenses, Permits,
Etc . Except as disclosed in Schedule 5.11,
|
(a)
the Company and its Subsidiaries own or possess all licenses,
permits, franchises, authorizations, patents, copyrights,
proprietary software, service marks, trademarks and trade names, or
rights thereto, that individually or in the aggregate are Material,
without known conflict with the rights of others except to the
extent any such conflict would not have a Material Adverse
Effect;
|
-11-
|
(b)
no product of the Company or any of its Subsidiaries infringes in
any Material respect any license, permit, franchise, authorization,
patent, copyright, proprietary software, service mark, trademark,
trade name or other right owned by any other Person except to the
extent any such infringement would not have a Material Adverse
Effect; and
|
|
(c)
there is no Material violation by any Person of any right of the
Company or any of its Subsidiaries with respect to any patent,
copyright, proprietary software, service mark, trademark, trade
name or other right owned or used by the Company or any of its
Subsidiaries except to the extent any such violation would not have
a Material Adverse Effect.
|
Section 5.12.
Compliance with
ERISA . (a) The Company and each ERISA Affiliate have
operated and administered each Plan while such Plan was sponsored
or maintained by the Company or such ERISA Affiliate in compliance
with all applicable laws except for such instances of noncompliance
as have not resulted in and would not reasonably be expected to
result in a Material Adverse Effect. Neither the Company nor any
ERISA Affiliate has incurred any liability pursuant to Title I
or IV of ERISA or the penalty or excise tax provisions of the Code
relating to employee benefit plans (as defined in section 3 of
ERISA), and no event, transaction or condition has occurred or
exists that would reasonably be expected to result in the
incurrence of any such liability by the Company or any ERISA
Affiliate, or in the imposition of any Lien on any of the rights,
properties or assets of the Company or any ERISA Affiliate, in
either case pursuant to Title I or IV of ERISA or to such
penalty or excise tax provisions or to section 401(a)(29) or
412 of the Code or section 4068 of ERISA, other than such
liabilities or Liens as would not be individually or in the
aggregate Material.
(b)
The present value of the aggregate benefit liabilities under each
of the Plans (other than Multiemployer Plans) that are sponsored or
maintained by the Company or an ERISA Affiliate and that are
subject to Code Section 412 or Title IV of ERISA,
determined as of the end of such Plan’s most recently ended
plan year on the basis of the actuarial assumptions specified for
funding purposes in such Plan’s most recent actuarial
valuation report, did not exceed the aggregate current value of the
assets of such Plan allocable to such benefit liabilities by more
than $24,367,000 in the aggregate for all Plans. The term
“benefit liabilities” has the meaning specified
in section 4001 of ERISA and the terms “current
value” and “present value” have the
meaning specified in section 3 of ERISA.
(c)
The Company and its ERISA Affiliates have not incurred any
withdrawal liabilities (and are not subject to contingent
withdrawal liabilities) under section 4201 or 4204 of ERISA in
respect of Multiemployer Plans that individually or in the
aggregate are Material.
(d)
The expected post-retirement benefit obligation (determined as of
the last day of the Company’s most recently ended fiscal year
in accordance with Financial Accounting Standards Board Statement
No. 106, without regard to liabilities attributable to
continuation coverage mandated by section 4980B of the Code)
of the Company and its Subsidiaries is not Material.
-12-
(e)
The execution and delivery of this Agreement and the issuance and
sale of the Series 2007A Notes hereunder will not involve any
transaction that is subject to the prohibitions of Section 406
of ERISA or in connection with which a tax would be imposed
pursuant to Section 4975(c)(1)(A)-(D) of the Code. The
representation by the Company in the first sentence of this
Section 5.12(e) is made in reliance upon and subject to the
accuracy of each Purchaser’s representation in
Section 6.3 as to the sources of the funds to be used to pay
the purchase price of the Series 2007A Notes to be purchased
by such Purchaser.
Section 5.13.
Private Offering by
the Company . Neither the Company nor anyone acting on the
Company’s behalf has offered the Series 2007A Notes or
any similar securities for sale to, or solicited any offer to buy
any of the same from, or otherwise approached or negotiated in
respect thereof with, any Person other than the Purchasers and not
more than 45 other Institutional Investors, each of which has been
offered the Series 2007A Notes in connection with a private
sale for investment. Neither the Company nor anyone acting on its
behalf has taken, or will take, any action that would subject the
issuance or sale of the Series 2007A Notes to the registration
requirements of Section 5 of the Securities Act or to the
registration requirements of any securities or blue sky laws of any
applicable jurisdiction.
Section 5.14.
Use of Proceeds;
Margin Regulations . The Company will apply the proceeds of the
sale of the Series 2007A Notes for general corporate purposes
of the Company. No part of the proceeds from the sale of the
Series 2007A Notes hereunder will be used, directly or
indirectly, for the purpose of buying or carrying any margin stock
within the meaning of Regulation U of the Board of Governors
of the Federal Reserve System (12 CFR 221), or for the
purpose of buying or carrying or trading in any securities under
such circumstances as to involve the Company in a violation of
Regulation X of said Board (12 CFR 224) or to involve any
broker or dealer in a violation of Regulation T of said Board
(12 CFR 220). Margin stock does not constitute more than 5% of
the value of the consolidated assets of the Company and its
Subsidiaries and the Company does not have any present intention
that margin stock will constitute more than 5% of the value of such
assets. As used in this Section, the terms “margin
stock” and “purpose of buying or
carrying” shall have the meanings assigned to them in
said Regulation U.
Section 5.15.
Existing Debt; Future
Liens . (a) Except as described therein,
Schedule 5.15 sets forth a complete and correct list of all
outstanding Debt of the Company and its Subsidiaries as of
June 30, 2007, since which date there has been no Material
change in the amounts, interest rates, sinking funds, installment
payments or maturities of the Debt of the Company or its
Subsidiaries except in the ordinary course of business. Neither the
Company nor any Significant Subsidiary is in default and no waiver
of default is currently in effect, in the payment of any principal
or interest on any Debt of the Company or such Significant
Subsidiary, and no default exists with respect to any such Debt of
the Company or any Significant Subsidiary, that would permit (or
that with notice or the lapse of time, or both, would permit) one
or more Persons to cause such Debt to become due and payable before
its stated maturity or before its regularly scheduled dates of
payment.
-13-
(b)
Except as disclosed in Schedule 5.15, neither the Company nor any
Subsidiary has agreed or consented to cause or permit in the future
(upon the happening of a contingency or otherwise) any of its
property, whether now owned or hereafter acquired, to be subject to
a Lien prohibited under Section 10.5.
(c)
Neither the Company nor any Significant Subsidiary is a party to,
or otherwise subject to any provision contained in, any instrument
evidencing Debt of the Company or such Significant Subsidiary, any
agreement relating thereto or any other agreement (including, but
not limited to, its charter or other organizational document) which
limits the amount of, or otherwise imposes restrictions on the
incurring of, Debt of the Company, except as specifically indicated
in Schedule 5.15.
Section 5.16.
Foreign Assets
Control Regulations, Etc . (a) Neither the sale of the
Series 2007A Notes by the Company hereunder nor its use of the
proceeds thereof will violate the Trading with the Enemy Act, as
amended, or any of the foreign assets control regulations of the
United States Treasury Department (31 CFR, Subtitle B,
Chapter V, as amended) or any enabling legislation or
executive order relating thereto.
(b)
Neither the Company nor any Subsidiary is a Person described or
designated in the Specially Designated Nationals and Blocked
Persons List of the Office of Foreign Assets Control or in
Section 1 of the Anti-Terrorism Order or, to the knowledge of
the Company, engages in any dealings or transactions with any such
Person. The Company and its Subsidiaries are in compliance, in all
material respects, with the USA Patriot Act.
(c)
No part of the proceeds from the sale of the Series 2007A
Notes hereunder will be used, directly or indirectly, for any
payments to any governmental official or employee, political party,
official of a political party, candidate for political office, or
anyone else acting in an official capacity, in order to obtain,
retain or direct business or obtain any improper advantage, in
violation of the United States Foreign Corrupt Practices Act of
1977, as amended, assuming in all cases that such Act applies to
the Company.
Section 5.17.
Status under Certain
Statute s. Neither the Company nor any Subsidiary is an
“investment company” registered or required to be
registered under the Investment Company Act of 1940, as amended, or
is subject to regulation under the Public Utility Holding Company
Act of 2005, as amended, the ICC Termination Act of 1995, as
amended, or the Federal Power Act, as amended.
Section 5.18.
Environmental
Matters . (a) Neither the Company nor any Subsidiary has
knowledge of any claim or has received any notice of any claim, and
no proceeding has been instituted raising any claim against the
Company or any of its Subsidiaries or any of their respective real
properties now or formerly owned, leased or operated by any of
them, or other assets, alleging any damage to the environment or
violation of any Environmental Laws, except, in each case, such as
would not reasonably be expected to result in a Material Adverse
Effect.
(b)
Neither the Company nor any Subsidiary has knowledge of any facts
which would reasonably be expected to give rise to any claim,
public or private, against the Company for violation of
Environmental Laws or damage to the environment emanating from,
occurring on or in any way related to real properties now or
formerly owned, leased or operated by any of them or to other
assets or their use, except, in each case, such as would not
reasonably be expected to result in a Material Adverse
Effect.
-14-
(c)
Neither the Company nor any of its Subsidiaries has stored any
Hazardous Materials on real properties now or formerly owned,
leased or operated by any of them or has disposed of any Hazardous
Materials in each case in a manner contrary to any Environmental
Laws in each case in any manner that would reasonably be expected
to result in a Material Adverse Effect.
(d)
All buildings on all real properties now owned, leased or operated
by the Company or any of its Subsidiaries are in compliance with
applicable Environmental Laws, except where failure to comply would
not reasonably be expected to result in a Material Adverse
Effect.
Section 5.19.
Notes Rank Pari
Passu. The obligations of the Company under this Agreement and
the Notes rank pari passu in right of payment with all other
senior unsecured Debt (actual or contingent) of the
Company.
SECTION
6. REPRESENTATIONS OF THE
PURCHASER.
Section 6.1.
Purchase for
Investment . Each Purchaser severally represents that it is
purchasing the Series 2007A Notes for its own account or for
one or more separate accounts maintained by it or for the account
of one or more pension or trust funds and not with a view to the
distribution thereof (other than any Notes purchased by Banc of
America Securities LLC on the Closing Date which are intended to be
resold to a “qualified institutional buyer” pursuant to
Rule 144A of the Securities Act), provided that the
disposition of such Purchaser’s or such pension or trust
funds’ property shall at all times be within such
Purchaser’s or such pension or trust funds’ control.
Each Purchaser understands that the Series 2007A Notes have
not been registered under the Securities Act and may be resold only
if registered pursuant to the provisions of the Securities Act or
if an exemption from registration is available, except under
circumstances where neither such registration nor such an exemption
is required by law, and that the Company is not required to
register the Series 2007A Notes.
Section 6.2.
Accredited
Investor . Each Purchaser represents that it is an
“accredited investor” (as defined in Rule 501(a)(1),
(2), (3) or (7) of Regulation D under the Securities Act acting for
its own account (and not for the account of others) or as a
fiduciary or agent for others (which others are also
“accredited investors”). Each Purchaser further
represents that such Purchaser has had the opportunity to ask
questions of the Company and received answers concerning the terms
and conditions of the sale of the Series 2007A
Notes.
-15-
Section 6.3.
Source of Funds .
Each Purchaser severally represents that at least one of the
following statements is an accurate representation as to each
source of funds (a “Source” ) to be used by such
Purchaser to pay the purchase price of the Series 2007A Notes
to be purchased by such Purchaser hereunder:
|
(a)
the Source is an “insurance company general account”
(as the term is defined in the United States Department of
Labor’s Prohibited Transaction Exemption (
“PTE” ) 95-60) in respect of which the reserves
and liabilities (as defined by the annual statement for life
insurance companies approved by the National Association of
Insurance Commissioners (the “NAIC Annual
Statement” )) for the general account contract(s) held by
or on behalf of any employee benefit plan together with the amount
of the reserves and liabilities for the general account contract(s)
held by or on behalf of any other employee benefit plans maintained
by the same employer (or affiliate thereof as defined in PTE 95-60)
or by the same employee organization in the general account do not
exceed 10% of the total reserves and liabilities of the general
account (exclusive of separate account liabilities) plus surplus as
set forth in the NAIC Annual Statement filed with such
Purchaser’s state of domicile; or
|
|
(b)
the Source is a separate account that is maintained solely in
connection with such Purchaser’s fixed contractual
obligations under which the amounts payable, or credited, to any
employee benefit plan (or its related trust) that has any interest
in such separate account (or to any participant or beneficiary of
such plan (including any annuitant)) are not affected in any manner
by the investment performance of the separate account;
or
|
|
(c)
the Source is either (i) an insurance company pooled separate
account, within the meaning of PTE 90-1 or (ii) a bank collective
investment fund, within the meaning of the PTE 91-38 and, except as
disclosed by such Purchaser to the Company in writing pursuant to
this clause (c), no employee benefit plan or group of plans
maintained by the same employer or employee organization
beneficially owns more than 10% of all assets allocated to such
pooled separate account or collective investment fund;
or
|
|
(d)
the Source constitutes assets of an Òinvestment fundÓ
(within the meaning of Part V of PTE 84-14 (the
ÒQPAM ExemptionÓ)) managed by a Òqualified
professional asset managerÓ or ÒQPAMÓ (within the
meaning of Part V of the QPAM Exemption), no employee benefit
plan’s assets that are included in such investment fund, when
combined with the assets of all other employee benefit plans
established or maintained by the same employer or by an affiliate
(within the meaning of Section V(c)(1) of the QPAM Exemption)
of such employer or by the same employee organization and managed
by such QPAM, exceed 20% of the total client assets managed by such
QPAM, the conditions of Part I(c) and (g) of the QPAM Exemption are
satisfied, as of the last day of its most recent calendar quarter,
the QPAM does not own a 10% or more interest in the Company and no
person controlling or controlled by the QPAM (applying the
definition of ÒcontrolÓ in Section V(e) of the QPAM
Exemption) owns a 20% or more interest in the Company (or less than
20% but greater than 10%, if such person exercises control over the
management or policies of the Company by reason of its ownership
interest) and (i) the identity of such QPAM and (ii) the
names of all employee benefit plans whose assets are included in
such investment fund have been disclosed to the Company in writing
pursuant to this clause (d); or
|
-16-
|
(e)
the Source constitutes assets of a “plan(s)” (within
the meaning of Section IV of PTE 96-23 (the “INHAM
Exemption” )) managed by an “in-house asset
manager” or “INHAM” (within the meaning of Part
IV of the INHAM exemption), the conditions of Part I(a), (g) and
(h) of the INHAM Exemption are satisfied, neither the INHAM nor a
person controlling or controlled by the INHAM (applying the
definition of “control” in Section IV(d) of the INHAM
Exemption) owns a 5% or more interest in the Company and (i) the
identity of such INHAM and (ii) the name(s) of the employee benefit
plan(s) whose assets constitute the Source have been disclosed to
the Company in writing pursuant to this clause (e); or
|
|
(f)
the Source is a governmental plan; or
|
|
(g)
the Source is one or more employee benefit plans, or a separate
account or trust fund comprised of one or more employee benefit
plans, each of which has been identified to the Company in writing
pursuant to this clause (g); or
|
|
(h)
the Source does not include assets of any employee benefit plan,
other than a plan exempt from the coverage of ERISA.
|
As used in
this Section 6.3, the terms “employee benefit
plan,” “governmental plan,” and
“separate account” shall have the respective
meanings assigned to such terms in section 3 of ERISA.
SECTION
7. INFORMATION AS TO COMPANY.
Section 7.1.
Financial and
Business Information . The Company shall deliver to each holder
of Notes that is an Institutional Investor:
|
(a)
Quarterly Statements — within 60 days after the end of
each quarterly fiscal period in each fiscal year of the Company
(other than the last quarterly fiscal period of each such fiscal
year),
|
|
(i)
a consolidated balance sheet of the Company and its Subsidiaries as
at the end of such quarter, and
|
|
(ii)
consolidated statements of income and cash flows of the Company and
its Subsidiaries, for such quarter and (in the case of the second
and third quarters) for the portion of the fiscal year ending with
such quarter,
|
| |
setting forth in each case in comparative form the figures for
the corresponding periods in the previous fiscal year, all in
reasonable detail, prepared in accordance with GAAP applicable to
quarterly financial statements generally, and certified by a Senior
Financial Officer as fairly presenting, in all material respects,
the financial position of the companies being reported on and their
results of operations and cash flows, subject to the absence of
footnotes and to changes resulting from year-end adjustments,
provided that filing with the Securities and Exchange
Commission within the time period specified above of the
Company’s Quarterly Report on Form 10-Q prepared in
compliance with the requirements therefor shall be deemed to
satisfy the requirements of this Section 7.1(a), provided
further that the Company shall be deemed to have satisfied the
requirements of this Section 7.1(a) by filing of such form
10-Q only if it shall have given each Purchaser written notice of
such filing; |
-17-
|
(b)
Annual Statements — within 105 days after the end of
each fiscal year of the Company,
|
|
(i)
a consolidated balance sheet of the Company and its Subsidiaries,
as at the end of such year, and
|
|
(ii)
consolidated statements of income, changes in shareholders’
equity and cash flows of the Company and its Subsidiaries, for such
year,
|
| |
setting forth in each case in comparative form the figures for
the previous fiscal year, all in reasonable detail, prepared in
accordance with GAAP, and accompanied by an opinion thereon of
Deloitte & Touche LLP or another independent certified
public accountants of recognized national standing, which opinion
shall state that such financial statements present fairly, in all
material respects, the financial position of the companies being
reported upon and their results of operations and cash flows and
have been prepared in conformity with GAAP, and that the
examination of such accountants in connection with such financial
statements has been made in accordance with generally accepted
auditing standards, and that such audit provides a reasonable basis
for such opinion in the circumstances, provided that filing
with the Securities and Exchange Commission within the time period
specified above of the Company’s Annual Report on Form 10-K
for such fiscal year (together with the Company’s annual
report to shareholders, if any, prepared pursuant to
Rule 14a-3 under the Exchange Act) prepared in accordance with
the requirements therefor shall be deemed to satisfy the
requirements of this Section 7.1(b), provided
further that the Company shall be deemed to have satisfied
the requirements of this Section 7.1(b) by filing of such form
10-K only if it shall have given each Purchaser written notice of
such filing; |
|
(c)
SEC and Other Reports — except for filings referred to
in Section 7.1(a) and (b) above, promptly upon filing or
sending and, to the extent applicable, one copy of (i) each
financial statement, report, notice or proxy statement sent by the
Company or any Subsidiary to public securities holders generally,
and (ii) each regular or periodic report, each registration
statement that shall have become effective (without exhibits except
as expressly requested by such holder), and each final prospectus
and all amendments thereto filed by the Company or any Subsidiary
with the Securities and Exchange Commission and of all press
releases and other statements made available generally by the
Company or any Subsidiary to the public concerning developments
that are Material; provided that filing of Form 8-K
with the Securities and Exchange Commission within the time periods
required by the Securities and Exchange Act of 1934, as amended,
and the posting of press releases on the Company’s website
shall satisfy the obligations under this Section 7.1(c) so
long as the Company provides written notice of such filing and/or
posting;
|
-18-
|
(d)
Notice of Default or Event of Default — promptly, and
in any event within five Business Days after a Responsible Officer
becomes aware of the existence of any Default or Event of Default
or that any Person has given any notice or taken any action with
respect to a claimed default hereunder or that any Person has given
any notice or taken any action with respect to a claimed default of
the type referred to in Section 11(g), a written notice
specifying the nature and period of existence thereof and what
action the Company is taking or proposes to take with respect
thereto;
|
|
(e)
ERISA Matters — promptly, and in any event within five
Business Days after a Responsible Officer becomes aware of any of
the following, a written notice setting forth the nature thereof
and the action, if any, that the Company or an ERISA Affiliate
proposes to take with respect thereto:
|
|
(i)
with respect to any Plan, any reportable event, as defined in
Section 4043(c) of ERISA and the regulations thereunder, for
which notice thereof has not been waived pursuant to such
regulations as in effect on the date thereof; or
|
|
(ii)
the taking by the PBGC of steps to institute, or the threatening by
the PBGC of the institution of, proceedings under Section 4042
of ERISA for the termination of, or the appointment of a trustee to
administer, any Plan, or the receipt by the Company or any ERISA
Affiliate of a notice from a Multiemployer Plan that such action
has been taken by the PBGC with respect to such Multiemployer Plan;
or
|
|
(iii)
any event, transaction or condition that would result in the
incurrence of any liability by the Company or any ERISA Affiliate
pursuant to Title I or IV of ERISA or the imposition of a
penalty or excise tax under the provisions of the Code relating to
employee benefit plans, or the imposition of any Lien on any of the
rights, properties or assets of the Company or any ERISA Affiliate
pursuant to Title I or IV of ERISA or such penalty or excise
tax provisions, if such liability or Lien, taken together with any
other such liabilities or Liens then existing, would reasonably be
expected to have a Material Adverse Effect;
|
|
(f)
Notices from Governmental Authority — promptly, and in
any event within 30 days of receipt thereof, copies of any notice
to t
|
|